首页> 外文期刊>Clinical biomechanics >Effects of Parkinson's disease and levodopa on functional limits of stability.
【24h】

Effects of Parkinson's disease and levodopa on functional limits of stability.

机译:帕金森氏病和左旋多巴对稳定性功能极限的影响。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: The voluntary, maximum inclined posture reflects the self-perceived limits of stability. Parkinson's disease is associated with small, bradykinetic postural weight shifts while standing but it is unclear whether this is due to reduced limits of stability and/or to the selection of abnormal strategies for leaning. The aim of this study was to investigate the effects of Parkinson's disease and levodopa medication on voluntary limits of stability and strategies used to reach these limits. METHODS: Fourteen subjects with Parkinson's disease (OFF and ON levodopa) and 10 age-matched controls participated in the study. Functional limits of stability were quantified as the maximum center of pressure excursion during voluntary forward and backward leaning. Postural strategies to achieve functional limits of stability were assessed by (i) body segments alignment, (ii) the difference between center of pressure and center of mass in preparation for a lean, (iii) the timing and the velocity of the preparation phase. FINDINGS: Functional limits of stability were significantly smaller in subjects with Parkinson's disease compared to control subjects. Subjects with Parkinson's disease maintained their stooped posture while leaning, initiated leaning with a smaller difference between center of pressure and center of mass and had a slower leaning velocity compared to control subjects. Levodopa enlarged the limits of stability in subjects with Parkinson's disease because of an increase in maximum forward, but not backward leans, but did not significantly improve postural alignment, preparation for a leaning movement, or velocity of leaning. INTERPRETATION: Parkinson's disease reduces functional limits of stability as well as the magnitude and velocity of postural preparation during voluntary, forward and backward leaning while standing. Levodopa improves the limits of stability but not the postural strategies used to achieve the leaning.
机译:背景:自愿的最大倾斜姿势反映了自我感知的稳定性极限。帕金森氏病与站立时轻微的运动迟缓姿势性体重变化有关,但尚不清楚这是否是由于稳定性极限降低和/或选择了异常的倾斜策略所致。这项研究的目的是研究帕金森氏病和左旋多巴药物对自愿性稳定性极限的影响以及用于达到这些极限的策略。方法:十四名帕金森氏病(左旋和左旋多巴)和十名年龄匹配的对照组参加了研究。稳定性的功能极限被量化为自愿向前和向后倾斜过程中最大压力偏移中心。通过(i)身体节段对齐,(ii)准备瘦身时压力中心和质心之间的差异,(iii)准备阶段的时间和速度来评估达到稳定功能极限的姿势策略。结果:与对照组相比,帕金森氏病患者的稳定性功能极限明显更小。与对照组相比,帕金森氏病患者在倾斜时保持其弯腰姿势,以压力中心和质心之间的差异较小的方式开始倾斜,并且倾斜速度较慢。左旋多巴扩大了最大帕金森氏病患者的稳定性极限,因为最大向前斜度增加了,但向后倾斜度没有增加,但是并没有显着改善姿势调整,倾斜运动的准备或倾斜速度。解释:帕金森氏病降低了站立时主动,向前和向后倾斜期间稳定性的功能极限以及姿势准备的幅度和速度。左旋多巴改善了稳定性极限,但没有改善用于实现倾斜的姿势策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号